The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: An alts report

Philip E. Castle, Mark H. Stoler, Diane Solomon, Mark Schiffman

Research output: Contribution to journalArticle

147 Citations (Scopus)

Abstract

We examined the predictors (cytologic interpretations, pathology review, human papillomavirus [HPV] testing results, and colposcopic impressions) of precancer among 545 women with clinical center biopsy diagnoses of cervical intraepithelial neoplasia (CIN) 2 in the ASCUS LSIL Triage Study. Among women with a CIN 2 biopsy result, there was an increasing likelihood that the loop electrosurgical excision procedure (LEEP) tissue sample was diagnosed as precancer (CIN 3) with an increasing number of clinical risk factors of cervical precancer (high-grade squamous intraepithelial lesion [HSIL] cytology, high-grade colposcopy, detection of HPV type 16; Ptrend < .0005). In a multivariate model, using a case definition of worst histologic diagnosis made by the quality control pathology review of biopsy and LEEP tissue samples, HPV-16 was positively associated (odds ratio [OR], 4.8; 95% confidence interval [CI], 2.6-8.8) with a CIN 3 diagnosis, whereas testing negative for HPV or positive for noncarcinogenic HPV types was negatively associated (OR, 0.32; 95% CI, 0.14-0.75) with a CIN 3 diagnosis. Although we found clear evidence that HPV-16 detection helped clarify whether a biopsy specimen diagnosed as CIN 2 represented HPV infection or cervical precancer, this relationship was not sufficiently robust to be clinically useful for reducing the overtreatment of women with HPV infection.

Original languageEnglish (US)
Pages (from-to)805-815
Number of pages11
JournalAmerican Journal of Clinical Pathology
Volume127
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Cervical Intraepithelial Neoplasia
Quality Control
Pathology
Biopsy
Human papillomavirus 16
Papillomavirus Infections
Odds Ratio
Confidence Intervals
Colposcopy
Triage
Cell Biology

Keywords

  • Biopsy
  • Cervical intraepithelial neoplasia
  • CIN
  • Colposcopy
  • Cytology
  • HPV
  • Human papillomavirus
  • Loop electrosurgical excision procedure

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses : An alts report. / Castle, Philip E.; Stoler, Mark H.; Solomon, Diane; Schiffman, Mark.

In: American Journal of Clinical Pathology, Vol. 127, No. 5, 05.2007, p. 805-815.

Research output: Contribution to journalArticle

@article{bcdb9835fded47ee9118a801f95e894e,
title = "The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: An alts report",
abstract = "We examined the predictors (cytologic interpretations, pathology review, human papillomavirus [HPV] testing results, and colposcopic impressions) of precancer among 545 women with clinical center biopsy diagnoses of cervical intraepithelial neoplasia (CIN) 2 in the ASCUS LSIL Triage Study. Among women with a CIN 2 biopsy result, there was an increasing likelihood that the loop electrosurgical excision procedure (LEEP) tissue sample was diagnosed as precancer (CIN 3) with an increasing number of clinical risk factors of cervical precancer (high-grade squamous intraepithelial lesion [HSIL] cytology, high-grade colposcopy, detection of HPV type 16; Ptrend < .0005). In a multivariate model, using a case definition of worst histologic diagnosis made by the quality control pathology review of biopsy and LEEP tissue samples, HPV-16 was positively associated (odds ratio [OR], 4.8; 95{\%} confidence interval [CI], 2.6-8.8) with a CIN 3 diagnosis, whereas testing negative for HPV or positive for noncarcinogenic HPV types was negatively associated (OR, 0.32; 95{\%} CI, 0.14-0.75) with a CIN 3 diagnosis. Although we found clear evidence that HPV-16 detection helped clarify whether a biopsy specimen diagnosed as CIN 2 represented HPV infection or cervical precancer, this relationship was not sufficiently robust to be clinically useful for reducing the overtreatment of women with HPV infection.",
keywords = "Biopsy, Cervical intraepithelial neoplasia, CIN, Colposcopy, Cytology, HPV, Human papillomavirus, Loop electrosurgical excision procedure",
author = "Castle, {Philip E.} and Stoler, {Mark H.} and Diane Solomon and Mark Schiffman",
year = "2007",
month = "5",
doi = "10.1309/PT3PNC1QL2F4D2VL",
language = "English (US)",
volume = "127",
pages = "805--815",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses

T2 - An alts report

AU - Castle, Philip E.

AU - Stoler, Mark H.

AU - Solomon, Diane

AU - Schiffman, Mark

PY - 2007/5

Y1 - 2007/5

N2 - We examined the predictors (cytologic interpretations, pathology review, human papillomavirus [HPV] testing results, and colposcopic impressions) of precancer among 545 women with clinical center biopsy diagnoses of cervical intraepithelial neoplasia (CIN) 2 in the ASCUS LSIL Triage Study. Among women with a CIN 2 biopsy result, there was an increasing likelihood that the loop electrosurgical excision procedure (LEEP) tissue sample was diagnosed as precancer (CIN 3) with an increasing number of clinical risk factors of cervical precancer (high-grade squamous intraepithelial lesion [HSIL] cytology, high-grade colposcopy, detection of HPV type 16; Ptrend < .0005). In a multivariate model, using a case definition of worst histologic diagnosis made by the quality control pathology review of biopsy and LEEP tissue samples, HPV-16 was positively associated (odds ratio [OR], 4.8; 95% confidence interval [CI], 2.6-8.8) with a CIN 3 diagnosis, whereas testing negative for HPV or positive for noncarcinogenic HPV types was negatively associated (OR, 0.32; 95% CI, 0.14-0.75) with a CIN 3 diagnosis. Although we found clear evidence that HPV-16 detection helped clarify whether a biopsy specimen diagnosed as CIN 2 represented HPV infection or cervical precancer, this relationship was not sufficiently robust to be clinically useful for reducing the overtreatment of women with HPV infection.

AB - We examined the predictors (cytologic interpretations, pathology review, human papillomavirus [HPV] testing results, and colposcopic impressions) of precancer among 545 women with clinical center biopsy diagnoses of cervical intraepithelial neoplasia (CIN) 2 in the ASCUS LSIL Triage Study. Among women with a CIN 2 biopsy result, there was an increasing likelihood that the loop electrosurgical excision procedure (LEEP) tissue sample was diagnosed as precancer (CIN 3) with an increasing number of clinical risk factors of cervical precancer (high-grade squamous intraepithelial lesion [HSIL] cytology, high-grade colposcopy, detection of HPV type 16; Ptrend < .0005). In a multivariate model, using a case definition of worst histologic diagnosis made by the quality control pathology review of biopsy and LEEP tissue samples, HPV-16 was positively associated (odds ratio [OR], 4.8; 95% confidence interval [CI], 2.6-8.8) with a CIN 3 diagnosis, whereas testing negative for HPV or positive for noncarcinogenic HPV types was negatively associated (OR, 0.32; 95% CI, 0.14-0.75) with a CIN 3 diagnosis. Although we found clear evidence that HPV-16 detection helped clarify whether a biopsy specimen diagnosed as CIN 2 represented HPV infection or cervical precancer, this relationship was not sufficiently robust to be clinically useful for reducing the overtreatment of women with HPV infection.

KW - Biopsy

KW - Cervical intraepithelial neoplasia

KW - CIN

KW - Colposcopy

KW - Cytology

KW - HPV

KW - Human papillomavirus

KW - Loop electrosurgical excision procedure

UR - http://www.scopus.com/inward/record.url?scp=34249025057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249025057&partnerID=8YFLogxK

U2 - 10.1309/PT3PNC1QL2F4D2VL

DO - 10.1309/PT3PNC1QL2F4D2VL

M3 - Article

C2 - 17439841

AN - SCOPUS:34249025057

VL - 127

SP - 805

EP - 815

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -